Breast cancer molecular diagnostics in Rwanda: a cost-minimization study of immunohistochemistry versus a novel GeneXpert ® mRNA expression assay.

Objective To compare the financial and time cost of breast cancer biomarker analysis by immunohistochemistry with that by the Xpert ® STRAT4 assay. Methods We estimated costs (personnel, location, consumables and indirect) and time involved in breast cancer diagnosis at the Butaro Cancer Centre of E...

Descripción completa

Detalles Bibliográficos

Publicado en:	Bulletin of the World Health Organization Vol. 101; no. 1; pp. 10 - 20
Autores principales:	Erfani, Parsa, Gaga, Esther, Hakizimana, Emmanuel, Kayitare, Emmanuel, Mugunga, Jean Claude, Shyirambere, Cyprien, Milner, Dan A., Shulman, Lawrence N., Ruhangaza, Deogratias, Fadelu, Temidayo
Formato:	research tables/charts Journal Article
Publicado:	World Health Organization Jan2023
Acceso en línea:	Ver este registro en EBSCOhost